Plandai Biotechnology, Inc. Receives Halaal Certification for Senteeko Facility
LOGAN, UT–(Marketwired – December 12, 2014) -Plandaí Biotechnology, Inc. (PLPL) (“Plandaí” or “the Company”), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that Green Gold Biotechnologies Inc., a South African subsidiary of Plandaí which runs the Senteeko production facility, has received Halaal Certification in South Africa. Halaal certification is the process that food producers undergo to establish that they are producing products in accordance with Islamic Law and is seen as a necessary step before shipments can commence to various parts of the world.
The certification process entails completing an application where the production methods are detailed and then undergoing inspections to verify the processes. Additionally, Halaal certified companies must implement procedures and supervisory protocols to ensure ongoing compliance in addition to being subjected to further inspections.
Callum Baylis-Duffield, Vice President of Sales and Marketing for Plandaí, commented, “With 21% of the world’s population identifying as Muslim, having Phytofare™ Halaal certified is an important step so that our customers can ensure the end consumers that the strictest manufacturing standards are being met. This certification opens the doors for us to market and sell to all areas of the globe and across many different product lines.”
The certification was awarded by the South African National Halaal Authority, an international, non-profit organization representing the Muslim Ummah on all matters pertaining to the general application of the term Halaal with specific reference to Islamic dietary laws. For additional information on Halaal and the certification process, visit their website athttps://www.sanha.org.za.
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company’s products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. For more information, please visit https://www.plandaibiotech.com.
Safe Harbor Statement
The information provided may contain forward-looking statements and involve risks and uncertainties. Results, events and performances could vary from those contemplated. These statements involve risks and uncertainties which may cause actual results, expressed or implied, to differ from predicted outcomes. Risks and uncertainties include product demand, market competition, and Plandaí’s ability to meet current or future plans. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Plandaí is not obliged to publicly release revisions to any forward-looking statement, to reflect events or circumstances afterward, or to disclose unanticipated occurrences, except as required under applicable laws.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | email@example.com